CALCIUM FOLIC ACID PLUS D CHEWABLE (CHOLECALCIFEROL, MAGNESIUM, BORON, FOLIC ACID, PYRIDOXINE, CYANOCOBALAMIN) WAFER [ACELLA PHARMACEUTICALS, LLC]

CALCIUM FOLIC ACID PLUS D CHEWABLE (CHOLECALCIFEROL, MAGNESIUM, BORON, FOLIC ACID, PYRIDOXINE, CYANOCOBALAMIN) WAFER [ACELLA PHARMACEUTICALS, LLC]
PDF | XML

NDC 42192-706-60
Set ID 9f89cb91-bd3b-4103-a8a1-c1c1512fe514
Category HUMAN PRESCRIPTION DRUG LABEL
Packager Acella Pharmaceuticals, LLC
Generic Name
Product Class
Product Number
Application Number
  • SPL UNCLASSIFIED SECTION

    Rx Only

  • DESCRIPTION

    Description: Calcium-Folic Acid Plus D Chewable Wafers are a chewable Calcium and Folic Acid Formula with Vitamin D, Magnesium and other nutrients for the maintenance and support of special dietary needs of any individual where supplementation with the ingredients contained within would prove beneficial including: premenopausal, menopausal and postmenopausal patients pertaining to the loss of calcium or calcium deficit, as well as cardiovascular wellness managed through dietary therapy.

    SUPPLEMENT FACTS
    Each Wafer Contains:
    Calcium Carbonate (Elemental 500 mg)1342 mg
    Vitamin D 3300 IU
    Magnesium50 mg
    Boron250 mcg
    Folic Acid1 mg
    Vitamin B 610 mg
    Vitamin B 12125 mcg

    Other Ingredients: Fructose, Natural Cocoa Dutch Chocolate, Stearic Acid, Plasdone, Natural Chocolate Flavor, Magnesium Stearate, Acacia Gum, Silicon Dioxide.

    Nutrition Information: Each wafer contains 11 calories and 2 grams of carbohydrates.

  • INDICATIONS & USAGE

    Indications and Usage: Calcium-Folic Acid Plus D Chewable Wafers are indicated, in addition to diet, to help satisfy the distinctive nutritional requirements of individuals under the supervision of a physician for the treatment of calcium deficiency, skeletal weakness and osteoporosis. Calcium-Folic Acid Plus D Chewable Wafers supplementation may be beneficial to individuals who have an insufficient dietary intake of the nutrients contained therein. Calcium and vitamin D supplementation may be useful in both preventing and treating osteoporosis. Vitamin D supplementation may be beneficial to those who are institutionalized and/or have reduced exposure to sunlight. Folic acid, vitamin B 6, and vitamin B 12, may help reduce the risk of cardiovascular disease by lowering blood levels of homocysteine. If dietary intake of calcium is inadequate, patients currently taking bisphosphonates for treatment of osteoporosis should be instructed to take calcium and vitamin D daily (Calcium-Folic Acid Plus D Chewable Wafers).

  • CONTRAINDICATIONS

    Contraindications: Calcium-Folic Acid Plus D Chewable Wafers are contraindicated in patients with hypersensitivity to any of its components. Calcium and vitamin D supplementation is contraindicated in those with hypercalcemia or conditions that may lead to hypercalcemia and those who form calcium containing stones are generally advised not to take supplemental calcium. Concomitant use of iron and calcium may inhibit the absorption of iron. Concomitant use of quinolones or tetracyclines with calcium may decrease the absorption of these medications. Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. The use of folic acid doses above 1 milligram/day may precipitate or exacerbate the neurological damage of vitamin B 12 deficiency. High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs; carbamazepine, fosphenytoin, phenytoin, phenobarbitol and valproic acid.

  • PRECAUTIONS

    Precautions: Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive.

  • DRUG INTERACTIONS

    Drug Interactions: As little as 5 mg of pyridoxine (vitamin B 6) daily can decrease the efficacy of levodopa. Therefore, Calcium-Folic Acid Plus D Chewable Wafers are not recommended for patients undergoing such therapy.

  • INFORMATION FOR PATIENTS

    Information for Patients: Calcium-Folic Acid Plus D Chewable Wafers are medical food for use only under the direction and supervision of a licensed physician. Total intakes of greater than 2,000 mg of calcium provide no added benefit to bone health.

  • PREGNANCY

    Pregnancy: Shall only be administered under the supervision of a physician.

  • PEDIATRIC USE

    Pediatric: Not recommended for pediatric use.

  • ADVERSE REACTIONS

    Adverse Reactions: Adverse reactions have been reported with specific vitamins and minerals, but generally at levels substantially higher than those in Calcium-Folic Acid Plus D Chewable Wafers. However, allergic and/or idiosyncratic reactions to vitamins even at lower potencies or any ingredient are possible.

  • WARNINGS

    Warning: Keep this and all medications out of the reach of children.

  • DOSAGE & ADMINISTRATION

    Dosage and Administration: Chew one wafer twice daily or as prescribed by a physician.

  • HOW SUPPLIED

    How Supplied: Brown-mottled, round shaped wafer, debossed on scored side with “BP 706”, plain on the other side. Calcium-Folic Acid Plus D Chewable Wafers are supplied in bottles of 60 wafers (42192-706-60). Store at room temperature, 15° - 30°C (59°- 86°F). Protect from light and moisture. The listed product number is not a National Drug Code, but has merely been formatted to comply with industry practice standard for pharmacy and insurance computer systems.

  • SPL UNCLASSIFIED SECTION

    All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. Please note: this is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical information provided herein.

    THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.

    Manufactured for:
    Acella Pharmaceuticals, LLC
    Alpharetta, GA 30022
    1-800-541-4802

    Rev.0313

  • PRINCIPAL DISPLAY PANEL - 60 wafers

    NDC 42192-706-60

    Calcium-Folic Acid Plus D

    Chewable Wafers

    Calcium Vitamin/Mineral
    Dietary Supplement

    R x Only          60 Wafers

    Acella
    PHARMACEUTICALS, LLC

    PRINCIPAL DISPLAY PANEL - 30 Softgels container
  • INGREDIENTS AND APPEARANCE
    CALCIUM FOLIC ACID PLUS D CHEWABLE 
    cholecalciferol, magnesium, boron, folic acid, pyridoxine, cyanocobalamin wafer
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42192-706
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CARBONATE1342 mg
    CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL300 [iU]
    MAGNESIUM (UNII: I38ZP9992A) (MAGNESIUM - UNII:I38ZP9992A) MAGNESIUM50 mg
    BORON (UNII: N9E3X5056Q) (BORON - UNII:N9E3X5056Q) BORON250 ug
    FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1 mg
    PYRIDOXINE (UNII: KV2JZ1BI6Z) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE10 mg
    CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN125 ug
    Inactive Ingredients
    Ingredient NameStrength
    FRUCTOSE (UNII: 6YSS42VSEV)  
    COCOA (UNII: D9108TZ9KG)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    POVIDONE K29/32 (UNII: 390RMW2PEQ)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    ACACIA (UNII: 5C5403N26O)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Product Characteristics
    ColorbrownScore2 pieces
    ShapeROUNDSize25mm
    FlavorImprint Code BP;706
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:42192-706-6060 in 1 BOTTLE; Type 0: Not a Combination Product03/20/200908/02/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other03/20/200908/02/2022
    Labeler - Acella Pharmaceuticals, LLC (825380939)
    Establishment
    NameAddressID/FEIBusiness Operations
    Acella Pharmaceuticals, LLC825380939manufacture(42192-706)